Human CR1 (Complement Receptor type 1) ELISA Kit (HUES03082)
- SKU:
- HUES03082
- Product Type:
- ELISA Kit
- Size:
- 96 Assays
- Uniprot:
- P17927
- Sensitivity:
- 0.09ng/mL
- Range:
- 0.16-10ng/mL
- ELISA Type:
- Sandwich
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
- Research Area:
- Immunology
Description
Human CR1 (Complement Receptor type 1) ELISA Kit
The Human CR1 (Complement Receptor Type 1) ELISA Kit is a cutting-edge assay designed for the precise measurement of CR1 levels in human samples such as serum, plasma, and cell culture supernatants. With its exceptional sensitivity and specificity, this kit delivers accurate and reproducible results, making it an invaluable tool for various research applications.CR1, also known as CD35, plays a critical role in the regulation of the immune response by binding to complement components and facilitating their clearance. Dysregulation of CR1 has been associated with various autoimmune diseases, inflammatory disorders, and infectious conditions, highlighting its importance as a biomarker for understanding and potentially treating these diseases.
Whether you are investigating the role of CR1 in immune system function, exploring its involvement in disease pathogenesis, or developing novel therapeutic strategies, the Human CR1 ELISA Kit offers a reliable and efficient solution for your research needs. Discover the power of precision with this advanced assay technology.
Assay type: | Sandwich |
Format: | 96T |
Assay time: | 4.5h |
Reactivity: | Human |
Detection Method: | Colormetric |
Detection Range: | 0.16-10 ng/mL |
Sensitivity: | 0.10 ng/mL |
Sample Volume Required Per Well: | 100µL |
Sample Type: | Serum, plasma and other biological fluids |
Specificity: | This kit recognizes Human CR1 in samples. No significant cross-reactivity or interference between Human CR1 and analogues was observed. |
This ELISA kit uses Sandwich-ELISA as the method. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CR1. Standards or samples are added to the appropriate micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CR1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CR1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by adding Stop Solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CR1. The concentration of Human CR1 in samples can be calculated by comparing the OD of the samples to the standard curve.
UniProt Protein Function: | CR1: Mediates cellular binding of particles and immune complexes that have activated complement. Belongs to the receptors of complement activation (RCA) family. |
UniProt Protein Details: | Protein type:Membrane protein, integral; Receptor, misc. Chromosomal Location of Human Ortholog: 1q32 Cellular Component: cell surface; integral to plasma membrane; plasma membrane Molecular Function:complement component C3b receptor activity; complement component C4b binding; complement component C4b receptor activity; complement component C3b binding Biological Process: negative regulation of complement activation, alternative pathway; complement receptor mediated signaling pathway; negative regulation of complement activation, classical pathway; regulation of complement activation; innate immune response; complement activation, classical pathway Disease: Knops Blood Group System; Malaria, Susceptibility To |
NCBI Summary: | This gene is a member of the receptors of complement activation (RCA) family and is located in the 'cluster RCA' region of chromosome 1. The gene encodes a monomeric single-pass type I membrane glycoprotein found on erythrocytes, leukocytes, glomerular podocytes, and splenic follicular dendritic cells. The Knops blood group system is a system of antigens located on this protein. The protein mediates cellular binding to particles and immune complexes that have activated complement. Decreases in expression of this protein and/or mutations in its gene have been associated with gallbladder carcinomas, mesangiocapillary glomerulonephritis, systemic lupus erythematosus and sarcoidosis. Mutations in this gene have also been associated with a reduction in Plasmodium falciparum rosetting, conferring protection against severe malaria. Alternate allele-specific splice variants, encoding different isoforms, have been characterized. Additional allele specific isoforms, including a secreted form, have been described but have not been fully characterized. [provided by RefSeq, Jul 2008] |
UniProt Code: | P17927 |
NCBI GenInfo Identifier: | 86793036 |
NCBI Gene ID: | 1378 |
NCBI Accession: | NP_000564. 2 |
UniProt Secondary Accession: | P17927,Q16744, Q16745, Q5SR43, Q5SR45, Q9UQV2, |
UniProt Related Accession: | P17927 |
Molecular Weight: | 223,663 Da |
NCBI Full Name: | complement receptor type 1 isoform F |
NCBI Synonym Full Names: | complement component (3b/4b) receptor 1 (Knops blood group) |
NCBI Official Symbol: | CR1 |
NCBI Official Synonym Symbols: | KN; C3BR; C4BR; CD35 |
NCBI Protein Information: | complement receptor type 1 |
UniProt Protein Name: | Complement receptor type 1 |
UniProt Synonym Protein Names: | C3b/C4b receptor; CD_antigen: CD35 |
Protein Family: | Complement receptor |
UniProt Gene Name: | CR1 |
UniProt Entry Name: | CR1_HUMAN |
As the OD values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration (ng/mL) | O.D | Average | Corrected |
10 | 2.465 2.511 | 2.488 | 2.435 |
5 | 1.592 1.608 | 1.6 | 1.547 |
2.5 | 0.98 0.978 | 0.979 | 0.926 |
1.25 | 0.459 0.475 | 0.467 | 0.414 |
0.63 | 0.273 0.247 | 0.26 | 0.207 |
0.32 | 0.163 0.155 | 0.159 | 0.106 |
0.16 | 0.106 0.108 | 0.107 | 0.054 |
0 | 0.051 0.055 | 0.053 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human CR1 were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human CR1 were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 0.49 | 1.49 | 3.54 | 0.53 | 1.44 | 3.55 |
Standard deviation | 0.03 | 0.07 | 0.11 | 0.03 | 0.08 | 0.19 |
C V (%) | 6.12 | 4.70 | 3.11 | 5.66 | 5.56 | 5.35 |
Recovery
The recovery of Human CR1 spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 87-100 | 93 |
EDTA plasma (n=5) | 91-104 | 98 |
Cell culture media (n=5) | 95-108 | 100 |
Linearity
Samples were spiked with high concentrations of Human CR1 and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 89-100 | 87-99 | 92-108 |
Average (%) | 95 | 93 | 99 | |
1:4 | Range (%) | 87-103 | 80-91 | 87-102 |
Average (%) | 94 | 86 | 94 | |
1:8 | Range (%) | 87-103 | 86-97 | 89-103 |
Average (%) | 94 | 91 | 95 | |
1:16 | Range (%) | 90-101 | 79-90 | 88-99 |
Average (%) | 96 | 85 | 93 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro ELISA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent | 1 vial, 10 mL | 4°C(shading light) |
Stop Solution | 1 vial, 10 mL | 4°C |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100µl of standard solutions into the standard wells.
- Add 100µl of Sample / Standard dilution buffer into the control (zero) well.
- Add 100µl of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37°C.
- Aspirate the liquid from each well, do not wash. Immediately add 100µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37°C.
- Aspirate or decant the solution from the plate and add 350µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37°C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 90µL of Substrate Reagent to each well. Cover with a new plate seal and incubate forapproximately 15 min at 37°C. Protect the plate from light. Note: the reaction time can beshortened or extended according to the actual color change, but not by more than 30min.
- Add 50 µL of Stop Solution to each well. Note: Adding the stop solution should be done inthe same order as the substrate solution.
- Determine the optical density (OD value) of each well immediately with a microplate readerset at 450 nm.